| HPV prevalence, n (%) | p Value* | |||
| All men (n = 129) | HIV-positive (n = 36) | HIV-negative (n = 93) | ||
| HPV-positive (any type) | 122 (94.6) | 35 (97.2) | 87 (93.5) | 0.407 |
| Any low-risk type† | 113 (87.6) | 32 (88.9) | 81 (87.1) | 0.781 |
| Any high-risk type† | 102 (79.1) | 34 (94.4) | 68 (73.1) | 0.008 |
| Low- and high-risk types† | 93 (72.1) | 31 (86.1) | 62 (66.7) | 0.028 |
| Low-risk only† | 20 (15.5) | 1 (2.8) | 19 (20.4) | 0.013 |
| High-risk only† | 9 (7.0) | 3 (8.3) | 6 (6.5) | 0.719 |
| Low-risk HPV types† | ||||
| 6 or 11 | 48 (37.2) | 21 (58.3) | 27 (29.0) | 0.002 |
| 6 | 35 (27.1) | 14 (38.9) | 21 (22.6) | 0.062 |
| 11 | 16 (12.4) | 8 (22.2) | 8 (8.6) | 0.036 |
| 26 | 2 (1.6) | 0 | 2 (2.2) | 0.370 |
| 40 | 7 (5.4) | 4 (11.1) | 3 (3.2) | 0.075 |
| 42 | 16 (12.4) | 6 (16.7) | 10 (10.8) | 0.363 |
| 53 | 33 (25.6) | 10 (27.8) | 23 (24.7) | 0.717 |
| 54 | 10 (7.8) | 1 (2.8) | 9 (9.7) | 0.189 |
| 55 | 20 (15.5) | 8 (22.2) | 12 (12.9) | 0.190 |
| 61 | 20 (15.5) | 4 (11.1) | 16 (17.2) | 0.390 |
| 62 | 19 (14.7) | 4 (11.1) | 15 (16.1) | 0.472 |
| 64 | 1 (0.8) | 0 | 1 (1.1) | 0.528 |
| 66 | 12 (9.3) | 3 (8.3) | 9 (9.7) | 0.806 |
| 67 | 3 (2.3) | 2 (5.6) | 1 (1.1) | 0.131 |
| 69 | 6 (4.7) | 4 (11.1) | 2 (2.2) | 0.032 |
| 70 | 21 (16.3) | 10 (27.8) | 11 (11.8) | 0.027 |
| 71 | 2 (1.6) | 0 | 2 (2.2) | 0.370 |
| 72 | 17 (13.2) | 6 (16.7) | 11 (11.8) | 0.460 |
| 73 | 18 (14.0) | 8 (22.2) | 10 (10.8) | 0.094 |
| 81 | 14 (10.9) | 7 (19.4) | 7 (7.5) | 0.051 |
| 82 | 13 (10.1) | 7 (19.4) | 6 (6.5) | 0.029 |
| 83 | 7 (5.4) | 2 (5.6) | 5 (5.4) | 0.964 |
| 84 | 18 (14.0) | 9 (25.0) | 9 (9.7) | 0.025 |
| High-risk HPV types† | ||||
| 16 or 18 | 50 (38.8) | 14 (38.9) | 36 (38.7) | 0.983 |
| 16 | 38 (29.5) | 13 (36.1) | 25 (26.9) | 0.304 |
| 18 | 23 (17.8) | 6 (16.7) | 17 (18.3) | 0.831 |
| 33 | 14 (10.9) | 5 (13.9) | 9 (9.7) | 0.492 |
| 35 | 18 (14.0) | 10 (27.8) | 8 (8.6) | 0.005 |
| 39 | 23 (17.8) | 10 (27.8) | 13 (14.0) | 0.066 |
| 45 | 25 (19.4) | 11 (30.6) | 14 (15.1) | 0.046 |
| 51 | 24 (18.6) | 13 (36.1) | 11 (11.8) | 0.001 |
| 52‡ | 10 (7.8) | 5 (13.9) | 5 (5.4) | 0.106 |
| 56 | 18 (14.0) | 9 (25.0) | 9 (9.7) | 0.025 |
| 58 | 18 (14.0) | 4 (11.1) | 14 (15.1) | 0.557 |
| 59 | 24 (18.6) | 9 (25.0) | 15 (16.1) | 0.244 |
| 68 | 15 (11.6) | 8 (22.2) | 7 (7.5) | 0.019 |
*p Value for difference in prevalence between HIV-positive and HIV-negative men.
†Low and high-risk HPV genotypes based on studies of HPV genotypes detected in cervical cancer.15
‡Type 52 HPV result is obtained from a combination probe strip including HPV genotypes 52, 33, 35 and 58. It is recorded as positive if the combination probe is positive, but the independent probes for genotypes 33, 35 and 58 are negative.